Lobbying activity

Q1

DAIICHI SANKYO, INC. for DAIICHI SANKYO INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Taxation/Internal Revenue Code, Health Issues

View → Q1

TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q1

TODD STRATEGY GROUP for ALEXION PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $80,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

MARSHALL & POPP, LLC for JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $40,000.00 income

Health Issues, Budget/Appropriations

View → Q1

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

TIBER CREEK GROUP for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $70,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

TIBER CREEK GROUP for DAIICHI SANKYO, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $50,000.00 income

Health Issues

View → Q1

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $40,000.00 income

Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

View → Q1

W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP

1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate · $80,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $20,000.00 income

Health Issues

View → Q1

LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $30,000.00 income

Medicare/Medicaid

View → Q1

LMH STRATEGIC SOLUTIONS for ALKERMES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income

Medicare/Medicaid

View → Q1

JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Pharmacy

View → Q1

TIBER CREEK GROUP for INCYTE CORPORATION

1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate · $70,000.00 income

Medicare/Medicaid

View → Q1

TIBER CREEK GROUP for ASTRAZENECA

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $90,000.00 income

Medicare/Medicaid

View → Q1

ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

ALKERMES, INC. for ALKERMES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate

Medicare/Medicaid, Health Issues, Alcohol and Drug Abuse

View → Q1

FEROX STRATEGIES for ALEXION PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Health Issues

View → Q1

UCB, INC. for UCB, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid

View → Q1

HEALTHCARE LEADERSHIP COUNCIL for HEALTHCARE LEADERSHIP COUNCIL

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid

View → Q1

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate

Health Issues

View → Q1

PUBLIC CITIZEN for PUBLIC CITIZEN

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products

View →